Inozyme Pharma Inc’s recent filing unveils that its CEO & Chairman Treco Douglas A unloaded Company’s shares for reported $7849.0 on Apr 02 ’25. In the deal valued at $0.89 per share,8,819 shares were sold. As a result of this transaction, Treco Douglas A now holds 41,046 shares worth roughly $41046.0.
Raymond James initiated its Inozyme Pharma Inc [INZY] rating to an Outperform in a research note published on December 12, 2024; the price target was $26. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Wells Fargo started covering the stock on May 30, 2024. It rated INZY as “an Overweight”.
Price Performance Review of INZY
On Tuesday, Inozyme Pharma Inc [NASDAQ:INZY] saw its stock jump 2.90% to $1.00. Over the last five days, the stock has gained 16.59%. Inozyme Pharma Inc shares have fallen nearly -64.00% since the year began. Nevertheless, the stocks have fallen -80.60% over the past one year. While a 52-week high of $6.24 was reached on 01/03/25, a 52-week low of $0.72 was recorded on 04/07/25. SMA at 50 days reached $1.1068, while 200 days put it at $3.3656.
Levels Of Support And Resistance For INZY Stock
The 24-hour chart illustrates a support level at 0.9381, which if violated will result in even more drops to 0.8791. On the upside, there is a resistance level at 1.0681. A further resistance level may holdings at 1.1391. The Relative Strength Index (RSI) on the 14-day chart is 50.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0425, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.00%. Stochastics %K at 70.31% indicates the stock is a holding.
How much short interest is there in Inozyme Pharma Inc?
A steep rise in short interest was recorded in Inozyme Pharma Inc stocks on 2025-03-31, dropping by -0.18 million shares to a total of 4.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 4.39 million shares. There was a decline of -4.26%, which implies that there is a negative sentiment for the stock.
